Loading clinical trials...
Loading clinical trials...
A Placebo-Controlled, Double-masked Phase-1 Study in Healthy Subjects Investigating the Safety and Tolerability of Laquinimod Eye Drops
Conditions
Interventions
Laquinimod
Placebo
Locations
1
Austria
Clinical trial center at Medical University Vienna
Vienna, Austria
Start Date
December 9, 2021
Primary Completion Date
January 19, 2023
Completion Date
January 19, 2023
Last Updated
January 31, 2023
NCT07228793
NCT06177639
NCT05147701
NCT06112340
NCT06070467
NCT06451172
Lead Sponsor
Active Biotech AB
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions